RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Conditions
Adenocarcinoma of Lung · Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Dr. Amit Kulkarni, Phoenix, Arizona, United States
MNCCTN Essentia Health St. Joseph's Brainerd Medical Center, Brainerd, Minnesota, United States
MNCCTN Essentia Health Deer River, Deer River, Minnesota, United States
MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic, Detroit Lakes, Minnesota, United States
MNCCTN Essentia Health Duluth, Duluth, Minnesota, United States
MNCCTN Essentia Health Fosston, Fosston, Minnesota, United States
MNCCTN Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
MNCCTN Essentia Health Sandstone, Sandstone, Minnesota, United States
MNCCTN Essentia Health Virginia Clinic, Virginia, Minnesota, United States
Study leads
Manish Patel, DO
Principal Investigator
University of Minnesota, Division of Hematology, Oncology and Transplantation